SAN DIEGO, June 6, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, inclusive (the "Class Period"), have until July 28, 2025 to seek...
Read More Details
Finally We wish PressBee provided you with enough information of ( URGN INVESTOR DEADLINE: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit )
Also on site :
- Today’s NYT ‘Strands’ Hints, Spangram and Answers for Saturday, June 7
- Taylor Swift and Travis Kelce Dance At Surprising Backyard Wedding Appearance
- NYT Connections Sports Edition Today: Hints and Answers for June 7